Open Access

New opportunities for an old problem: lowering potassium to maximize heart failure therapy

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure
Topic: Chronic Ischaemic heart disease
Session type: Satellite Symposium
Organised by Lorraine University, supported by an unrestricted educational grant from AstraZeneca
Date: 29 April 2017
Time: 13:30 - 14:30

Session

4 presentations in this session

Chair's introduction.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Thumbnail

The unseen impact of hyperkalemia: implications of suboptimal renin–angiotensin–aldosterone system inhibitor therapy.

Speaker: Professor J. Cleland (Glasgow, GB)
Thumbnail

Managing potassium to optimize therapy for heart failure.

Speaker: Professor P. Van Der Meer (Groningen, NL)
Thumbnail

Panel Q&A / Discussion.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)
Speaker: Professor J. Cleland (Glasgow, GB)
Speaker: Professor P. Van Der Meer (Groningen, NL)
Thumbnail

6 speakers from this session

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
69 presentations
0 follower

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
56 presentations
2 followers

Professor Peter Van Der Meer

University Medical Center Groningen, Groningen (Netherlands (The))
40 presentations
0 follower

Professor Faiez Zannad

University of Lorraine, Vandoeuvre-Les-Nancy (France)
69 presentations
0 follower

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
56 presentations
2 followers

Professor Peter Van Der Meer

University Medical Center Groningen, Groningen (Netherlands (The))
40 presentations
0 follower

This platform is supported by

logo Novo Nordisk